Integrating Bulk-seq and Single-cell-seq Reveals Estrogen and MAPK Pathways Associating with Neuroblastoma Outcome
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Integrating Bulk-seq and Single-cell-seq Reveals Estrogen and MAPK Pathways Associating with Neuroblastoma Outcome
Authors
Keywords
-
Journal
Cancer Control
Volume 30, Issue -, Pages 107327482311781
Publisher
SAGE Publications
Online
2023-05-23
DOI
10.1177/10732748231178177
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Single-cell transcriptomic analyses provide insights into the developmental origins of neuroblastoma
- (2021) Selina Jansky et al. NATURE GENETICS
- oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data
- (2021) Danielle Maeser et al. BRIEFINGS IN BIOINFORMATICS
- A review of the biological and clinical implications of RAS-MAPK pathway alterations in neuroblastoma
- (2021) Vid Mlakar et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The MYC oncogene — the grand orchestrator of cancer growth and immune evasion
- (2021) Renumathy Dhanasekaran et al. Nature Reviews Clinical Oncology
- IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures
- (2021) Dongqiang Zeng et al. Frontiers in Immunology
- The role of delta-like non-canonical Notch ligand 1 (DLK1) in cancer
- (2021) James F H Pittaway et al. ENDOCRINE-RELATED CANCER
- Emerging Roles of DLK1 in the Stem Cell Niche and Cancer Stemness
- (2021) Elisa Stellaria Grassi et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- NTRK1/TrkA Activation Overrides the G2/M-Checkpoint upon Irradiation
- (2021) Christina Hassiepen et al. Cancers
- Identification of a Five-Gene Signature Derived From MYCN Amplification and Establishment of a Nomogram for Predicting the Prognosis of Neuroblastoma
- (2021) Yuren Xia et al. Frontiers in Molecular Biosciences
- Monitoring Immune Responses in Neuroblastoma Patients during Therapy
- (2020) Celina L. Szanto et al. Cancers
- ER and PI3K Pathway Activity in Primary ER Positive Breast Cancer Is Associated with Progression-Free Survival of Metastatic Patients under First-Line Tamoxifen
- (2020) Anieta M. Sieuwerts et al. Cancers
- Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma
- (2020) Lucas Moreno et al. EUROPEAN JOURNAL OF CANCER
- Pan-neuroblastoma analysis reveals age- and signature-associated driver alterations
- (2020) Samuel W. Brady et al. Nature Communications
- Targeting the p53-MDM2 pathway for neuroblastoma therapy: Rays of hope
- (2020) Atif Zafar et al. CANCER LETTERS
- The immune landscape of neuroblastoma: Challenges and opportunities for novel therapeutic strategies in pediatric oncology
- (2020) Judith Wienke et al. EUROPEAN JOURNAL OF CANCER
- Quizartinib (AC220): a promising option for acute myeloid leukemia
- (2019) Fang Zhou et al. Drug Design Development and Therapy
- FMS-like Tyrosine Kinase 3/FLT3: From Basic Science to Clinical Implications
- (2019) Julhash U. Kazi et al. PHYSIOLOGICAL REVIEWS
- Transfer of regulatory knowledge from human to mouse for functional genomic analysis
- (2019) Christian H. Holland et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Estrogen Receptor pathway activity score to predict clinical response or resistance to neo-adjuvant endocrine therapy in primary breast cancer
- (2019) Marcia A. Inda et al. MOLECULAR CANCER THERAPEUTICS
- FLT3 mutations in acute myeloid leukemia: Therapeutic paradigm beyond inhibitor development
- (2019) Hitoshi Kiyoi et al. CANCER SCIENCE
- Whole genome sequencing analysis for cancer genomics and precision medicine
- (2018) Hidewaki Nakagawa et al. CANCER SCIENCE
- Oncogenic Signaling Pathways in The Cancer Genome Atlas
- (2018) Francisco Sanchez-Vega et al. CELL
- Spontaneous regression of neuroblastoma
- (2018) Garrett M. Brodeur CELL AND TISSUE RESEARCH
- MYCN-amplified neuroblastoma maintains an aggressive and undifferentiated phenotype by deregulation of estrogen and NGF signaling
- (2018) Johanna Dzieran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibiting TRK Proteins in Clinical Cancer Therapy
- (2018) Allison Lange et al. Cancers
- Update on neuroblastoma
- (2018) Erika A. Newman et al. JOURNAL OF PEDIATRIC SURGERY
- NTRK fusion-positive cancers and TRK inhibitor therapy
- (2018) Emiliano Cocco et al. Nature Reviews Clinical Oncology
- Identification of Potential Prognostic Genes for Neuroblastoma
- (2018) Xiaodan Zhong et al. Frontiers in Genetics
- Precision Oncology: The Road Ahead
- (2017) Daniela Senft et al. TRENDS IN MOLECULAR MEDICINE
- Dinutuximab for the treatment of pediatric patients with high-risk neuroblastoma
- (2016) Jaume Mora Expert Review of Clinical Pharmacology
- Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): the TRIPOD Statement
- (2015) G. S. Collins et al. BRITISH JOURNAL OF SURGERY
- Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations
- (2015) Thomas F Eleveld et al. NATURE GENETICS
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- Tumor-infiltrating T lymphocytes improve clinical outcome of therapy-resistant neuroblastoma
- (2015) Marco Mina et al. OncoImmunology
- Regularization Paths for Generalized Linear Models via Coordinate Descent
- (2015) Jerome Friedman et al. Journal of Statistical Software
- Rare Variants in TP53 and Susceptibility to Neuroblastoma
- (2014) Sharon J. Diskin et al. JNCI-Journal of the National Cancer Institute
- NF-κB Signaling Pathway Confers Neuroblastoma Cells Migration and Invasion Ability via the Regulation of CXCR4
- (2014) Kun Yang MEDICAL SCIENCE MONITOR
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- Possible roles of DLK1 in the Notch pathway during development and disease
- (2012) Farah A. Falix et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- A Three-Gene Expression Signature Model for Risk Stratification of Patients with Neuroblastoma
- (2012) I. Garcia et al. CLINICAL CANCER RESEARCH
- ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking
- (2010) Matthew D. Wilkerson et al. BIOINFORMATICS
- Recent Advances in Neuroblastoma
- (2010) John M. Maris NEW ENGLAND JOURNAL OF MEDICINE
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
- (2009) David A. Barbie et al. NATURE
- Mechanisms of change in gene copy number
- (2009) P. J. Hastings et al. NATURE REVIEWS GENETICS
- PTEN and the PI3-Kinase Pathway in Cancer
- (2008) Nader Chalhoub et al. Annual Review of Pathology-Mechanisms of Disease
- Expression of KIT and PDGFR is associated with a good prognosis in neuroblastoma
- (2007) Akira Shimada et al. PEDIATRIC BLOOD & CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now